Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
2023
2021
Americas
Clear all
Type of publications
NITAG documentation
(69)
Systematic reviews (SYSVAC)
(5)
Topics
Available to download in languages
Regions
Americas
(74)
Africa
(25)
Eastern Mediterranean
(2)
Europe
(90)
South-East Asia
(4)
Western Pacific
(19)
Countries
Argentina
(2)
Bolivia
(2)
Canada
(21)
Chile
(10)
United States of America
(38)
Diseases
COVID-19
(74)
Dengue
(1)
Ebola
(1)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(6)
Influenza
(2)
Meningococcal disease
(3)
Pneumococcal disease
(4)
Poliomyelitis
(1)
Rotavirus
(2)
RSV (Respiratory syncytial virus)
(5)
Vaccine topics
Acceptance
(2)
Coverage
(1)
Ethical issues
(3)
Target population
Adults
(2)
All age groups
(4)
Children
(3)
Healthcare workers
(1)
Older adults
(1)
Parents/caregivers
(1)
Pregnant women
(4)
Publication date
2023
(10)
2021
(64)
2024
(1)
2022
(39)
2020
(62)
74 results found
2023
∙
Martin, P. Martin, R. DeBritz, A. A. Kang, A. W.
COVID-19 vaccination in correctional systems in the United States
2023
∙
Xiao, Hong Vaidya, Riha Liu, Fang Chang, Ximing Xia, Xiaoqian Unger, Joseph M.
Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis
2023
∙
CAVEI
CAVEI recommendation on updating the vaccination strategy against COVID-19 by 2024
2023
∙
CoNaIn
CoNaIn 9th November 2023 meeting minutes
2023
∙
NACI
Updated guidance on the use of COVID-19 vaccines in individuals who have not previously been vaccinated against COVID-19
2023
∙
ACIP
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months — United States, April 2023
2023
∙
NACI
Guidance on the use of COVID-19 vaccines in the fall of 2023
2023
∙
NACI
NACI Interim guidance on the use of bivalent Omicroncontaining COVID-19 vaccines for primary series
2023
∙
NACI
Guidance on an additional COVID-19 booster dose in the spring of 2023 for individuals at high risk of severe illness due to COVID-19
2023
∙
NACI
NACI guidance on COVID-19 vaccine booster doses: Initial considerations for 2023
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register